NCT04425707

Ivermectin In Treatment of COVID 19 Patients

The Use of Ivermectin In the Treatment of COVID 19 Patients

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Ministry of Health and Population, Egypt · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

as Egypt suffered a lot during the pandemic of COVID 19 with limited drug choices, many of the patients could not acheive viral clearence with the standard module of care teh idea of introduction of new medications in the treatment protocol of COVID 19 managment. Ivermectin had shown a promising results in vitro studies and in limited in vivo studies. this clinical trial may open a new hope for COVID 19 patients as a new and cheap line of treatment

Detailed description

the study will compare the effect of ivermectin in comaprison and addition to the standard mode of care for the COVID 19 patients

Conditions

• Covid19

Interventions

Type	Name	Description
DRUG	Ivermectin	use of Ivermectin in the treatment of COVID 19 patients, in comparison to and in addition to the standard care of treatment of COVID 19 in Egypt

Timeline

• Start date: 2020-06-09
• Primary completion: 2020-07-01
• Completion: 2020-09-01
• First posted: 2020-06-11
• Last updated: 2020-06-11

Locations

1 site across 1 country: Egypt